source
- Aspen Neuroscience raises $140M IPO to advance Parkinson’s cell therapyAspen Neuroscience, a San Diego biotechnology company, completed an initial public offering, selling roughly 9.4 million shares at $15 each and raising about $140.6 million. The capital will be di…
- AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expectedAstraZeneca announced a three-year cost‑saving initiative worth $1.5 billion during its third‑quarter earnings call. The program, called Reshaping for Sustainable Growth, aims to redeploy resource…